Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.

By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.

In Australia, a country where skin cancer rates remain high, cancer survivor Malcolm Caddies is on a mission to prevent the risks of sun exposure.

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.

Jennifer Allport-Anderson hunts for cardiac cures.

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Sandrine Piret-Gérard, Vice President and Head of US Hematology at Novartis, reflects on what’s inspired her career in health care.

More than 125 million people worldwide live with psoriasis, a chronic autoimmune disease that causes red, scaly patches to appear on the skin.